Insider holders · CIK 0001601830
RECURSION PHARMACEUTICALS, INC. · RXRX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Blake BorgesonDirector | 6,158,287 | — | 6,158,287 | Sep 2, 2026 · 6:01 pm EDT | Form 4 |
| Najat KhanCEO and President | 2,072,890 | — | 2,072,890 | Sep 10, 2026 · 5:55 pm EDT | Form 4 |
| Dean Y LiDirector | 1,473,329 | 421,000 | 1,894,329 | Jul 2, 2026 · 5:15 pm EDT | Form 4 |
| Ben R TaylorChief Financial Officer | 1,071,462 | — | 1,071,462 | Sep 16, 2026 · 5:52 pm EDT | Form 4 |
| David HallettChief Scientific Officer | 1,043,837 | — | 1,043,837 | Aug 18, 2026 · 5:44 pm EDT | Form 4 |
| Christopher GibsonDirector | 883,735 | — | 883,735 | Jun 5, 2026 · 5:03 pm EDT | Form 4 |
| Zavain DarDirector | 240,764 | — | 240,764 | Jul 2, 2026 · 5:15 pm EDT | Form 4 |
| Franziska MichorDirector | 215,477 | — | 215,477 | Jun 22, 2026 · 4:32 pm EDT | Form 4 |
| Robert HershbergDirector | 162,156 | — | 162,156 | Jun 22, 2026 · 4:32 pm EDT | Form 4 |
| Elaine D SunDirector | 135,981 | — | 135,981 | Jun 22, 2026 · 4:32 pm EDT | Form 4 |
| Namandje BumpusDirector | 127,632 | — | 127,632 | Jun 22, 2026 · 4:32 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.